Expertos Invitados





O (EL) WALKING IMPAIRMENT QUESTIONNAIRE EM INDIVIDUOS COM CLAUDICAÇAO INTERMITENTE

(especial para SIIC © Derechos reservados)
A quantificação da capacidade de locomoção dos (La cuantificación de la capacidad de movilidad de los) pacientes com claudicação intermitente é relevante para as condutas (es relevante para las conductas) terapêuticas a serem realizadas frente a esses pacientes. O Walking Impairment Questionnaire é um instrumento válido, reprodutível e que está relacionado com diferentes indicadores de saúde em (de salud en) pacientes com claudicação intermitente.
menendezritti9_103012.jpg Autor:
Raphael mendes Ritti-dias
Columnista Experto de SIIC

Institución:
Universidade de Pernambuco (UPE)

Artículos publicados por Raphael mendes Ritti-dias
Coautores
J Paulo dos Anjos Barbosa* B Remígio Cavalcante** R Marinho Falcão Batista** 
Mestre em Educação Física, Universidade de Pernambuco (UPE), Recife, Brasil*
Graduando em Educação Física, Universidade de Pernambuco (UPE), Recife, Brasil**
Recepción del artículo
22 de Julio, 2012 		Aprobación
1 de Octubre, 2012
Primera edición
5 de Noviembre, 2012 		Segunda edición, ampliada y corregida
7 de Junio, 2021

O (EL) WALKING IMPAIRMENT QUESTIONNAIRE EM INDIVIDUOS COM CLAUDICAÇAO INTERMITENTE

Resumen
Introdução: A quantificação da capacidade de locomoção dos pacientes com claudicação intermitente (CI) é relevante visto que pode fornecer subsídios para a as condutas terapêuticas a serem realizadas frente a esses pacientes. Para tanto, o Walking Impairment Questionnaire (WIQ) foi elaborado para quantificar a capacidade funcional em indivíduos com CI. Objetivo: Descrever os principais resultados dos estudos que utilizaram o WIQ em indivíduos com CI. Métodos: Foi realizada uma revisão narrativa da literatura com base nos estudos que utilizaram o WIQ. Resultados: O WIQ já foi traduzido e validado em diferentes idiomas, tais como inglês, holandês, espanhol, português e chinês, contra testes de esteira, de força e questionários de qualidade de vida. Em todos eles foram observadas correlações significantes que variaram de r=0,25 a r=0,86, e bons indicadores de reprodutibilidade que variaram de r=0,78 a r=0,94. Estudos demonstraram que os resultados do WIQ estão relacionados com os indicadores clínicos da doença, da qualidade de vida e da aptidão física. Além disso, os efeitos de programas de treinamento físico também são identificados pelo WIQ. Conclusão: O WIQ é um instrumento válido, reprodutível e que está relacionado com diferentes indicadores de saúde em pacientes com CI.

Palabras clave
doença arterial periférica, claudicação intermitente, limitação de locomoção, revisão


Artículo completo
(castellano)
Extensión:  +/-4.97 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

WALKING IMPAIRMENT QUESTIONNAIRE IN INDIVIDUALS WITH INTERMITENT CLAUDICATION

Abstract
Introduction: The quantification of walking capacity in patients with intermittent claudication (IC) is important since it can provide support for the therapeutic procedures used in these patients. The Walking Impairment Questionnaire (WIQ) was developed to quantify functional capacity in individuals with IC Purpose: To describe the main findings of studies which used WIQ in individuals with IC. Methods: A narrative review of the literature was performed based on the studies that had used WIQ. Results: WIQ has been translated and validated in different languages such as English, Dutch, Spanish, Portuguese and Chinese. WIQ domains have been validated against treadmill testing, strength and quality of life questionnaires. In all of them significant correlations were observed ranging from r = 0.25 to r = 0.86. The results of these studies showed good reliability of the instrument indicators, ranging from r = 0.78 to r = 0.94. The results of WIQ are related to the clinical indicators of disease, quality of life and physical fitness. Moreover, the effects of supervised exercise training are also detected with WIQ Conclusion: WIQ is a valid and reliable instrument that is related to several health indicators in patients with IC.

Key words
peripheral arterial disease, intermittent claudication, mobility limitation, review

Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Cardiología, Medicina Interna
Relacionadas: Atención Primaria, Cirugía, Geriatría, Medicina Deportiva, Medicina Familiar



Comprar este artículo
Extensión: 4.97 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Raphael Mendes Ritti-Dias, Universidade de Pernambuco, CEP: 52050, Av. Santos Dumont, 444 ap. 601. Aflitos - Pernambuco - Brasil., Recife, Brasil
Bibliografía del artículo
1. Durazzo AE, Sitrângulo CD, Presti C S, ES., Luccia N. Doença arterial obstrutiva periférica: que atenção temos dispensado à abordagem clínica dos pacientes? Jornal Vascular Brasileiro 2005(4):255-64, 2005.
2. Makdisse M, Pereira AdC, Brasil DdP, Borges JL, Machado-Coelho GLL, Krieger JL, et al. Prevalence and risk factors associated with peripheral arterial disease in the Hearts of Brazil Project. Arquivos Brasileiro Cardiologia 91(6):370-82, 2008.
3. Gardner AW, Montgomery PS, Afaq A. Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain. J Vasc Surg 46(1):79-86, 2007.
4. Gardner AW, Montgomery PS, Scott KJ, Afaq A, Blevins SM. Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg 46(6):1208-14, 2007.
5. Herman SD, Liu K, Tian L, Guralnik JM, Ferrucci L, Criqui MH, et al. Baseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial disease. J Am Geriatr Soc 57(12):2246-52, 2009.
6. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program Vasc Med 13(1):15-24, 2008.
7. Garg PK, Tian L, Criqui MH, Liu K, Ferrucci L, Guralnik JM, et al. Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation 114(3):242-8, 2006.
8. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of Walking Impairment by Questionnaire Patients with Peripheral Arterial Disease. Journal of Vascular Medicine and Biology 2(3):142-52, 1990.
9. Coyne KS, Margolis MK, Gilchrist KA, Grandy SP, Hiatt WR, Ratchford A, et al. Evaluating effects of method of administration on Walking Impairment Questionnaire. J Vasc Surg 38(2):296-304, 2003.
10. Jie W, Yan C, Bian RW, Mo YZ, Haidi W, Ling C. Validation of the Chinese version of the Walking Impairment Questionnaire in patients with both peripheral arterial disease and type 2 diabetes mellitus. Diab Vasc Dis Res 8(1):29-34, 2011.
11. Ritti-Dias RM, Gobbo LA, Cucato GG, Wolosker N, Jacob Filho W, Santarém JM, et al. Tradução e validação do Walking Impairment Questionnaire em brasileiros com claudicação intermitente. Arquivos Brasileiros de Cardiologia 92:143-9, 2009.
12. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with intermittent claudication. Journal of Vascular Medicine and Biology 2(3):142-52, 1990.
13. Collins TC, Suarez-Almazor M, Petersen NJ, O'Malley KJ. A Spanish translation of the Walking Impairment Questionnaire was validated for patients with peripheral arterial disease. J Clin Epidemiol 57(12):1305-15, 2004.
14. Verspaget M, Nicolaï SPA, Kruidenier LM, Welten RJTJ, Prins MH, Teijink JAW. Validation of the Dutch version of the Walking Impairment Questionnaire. European Journal of Vascular and Endovascular Surgery 37(1):56-61, 2009.
15. McDermott MM, Liu K, Guralnik JM, Martin GJ, Criqui MH, Greenland P. Measurement of walking endurance and walking velocity with questionnaire: Validation of the walking impairment questionnaire in men and women with peripheral arterial disease. Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 28(6):1072-81, 1998.
16. Jie Wang, Yan Cui, Bian R-W, Mo Y-Z, HaiDi Wu, Ling Chen. Validation of the Chinese version of the Walking Impairment Questionnaire in patients with both peripheral arterial disease and type 2 diabetes mellitus. Diabetes and Vascular Disease Research 8(1):29-34, 2011.
17. Verspaget M, Nicolai SP, Kruidenier LM, Welten RJ, Prins MH, Teijink JA. Validation of the Dutch version of the Walking Impairment Questionnaire. Eur J Vasc Endovasc Surg 37(1):56-61, 2009.
18. McDermott MM, Mehta S, Liu K, Guralnik JM, Martin GJ, Criqui MH, et al. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J Gen Intern Med 14(3):173-81, 1999.
19. Long J, Modrall JG, Parker BJ, Swann A, Welborn MB, Anthony T. Correlation between ankle-brachial index, symptoms, and health-related quality of life in patients with peripheral vascular disease. Journal of vascular surgery: official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 39(4):723-7, 2004.
20. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. Journal of Vascular Surgery 41(4):625-30, 2005.
21. McDermott MM, Ferrucci L, Guralnik JM, Dyer AR, Kiang Liu, Pearce WH, et al. The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vascular Medicine 15(4):251-7, 2010.
22. Feinglass J, McCarthy WJ, Slavensky R, Manheim LM, Martin GJ. Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. The Chicago Claudication Outcomes Research Group. J Vasc Surg 24(4):503-11; discussion 11-2, 1996.
23. Seidl EMF, Zannon CMLdC. Qualidade de vida e saúde: aspectos conceituais e metodológicos. Cadernos de Saúde Pública 20:580-8, 2004.
24. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 41(4):625-30, 2005.
25. Myers SA, Johanning JM, Stergiou N, Lynch TG, Longo GM, Pipinos, II. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease. J Vasc Surg 47(3):550-5, 2008.
26. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113(11):e463-654, 2006.
27. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26(2):81-157, 2007.
28. Langbein WE, Collins EG, Orebaugh C, Maloney C, Williams KJ, Littooy FN, et al. Increasing exercise tolerance of persons limited by claudication pain using polestriding. Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 35(5):887-93, 2002.
29. Carlon R, Morlino T, Maiolino P. Beneficial effects of exercise beyond the pain threshold in intermittent claudication. Ital Heart J 4(2):113-20, 2003.
30. Menard JR, Smith HE, Riebe D, Braun CM, Blissmer B, Patterson RB. Long-term results of peripheral arterial disease rehabilitation. J Vasc Surg 39(6):1186-92, 2004.
31. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, et al. Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication. JAMA: The Journal of the American Medical Association 301(2):165-74, 2009.
32. Nicolai SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg 50(1):89-94, 2009.
33. Saxton JM, Zwierska I, Blagojevic M, Choksy SA, Nawaz S, Pockley AG. Upper- versus lower-limb aerobic exercise training on health-related quality of life in patients with symptomatic peripheral arterial disease. J Vasc Surg 53(5):1265-73, 2011.
34. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation 123(5):491-8, 2011.
35. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 23(1):104-15, 1996.
36. Langbein WE, Collins EG, Orebaugh C, Maloney C, Williams KJ, Littooy FN, et al. Increasing exercise tolerance of persons limited by claudication pain using polestriding. J Vasc Surg 35(5):887-93, 2002.
37. Nicolai SP, Teijink JA, Prins MH. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg 52(2):348-55, 2010.
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008